Celgene Corp (CELG) Tops Q2 EPS by 2c; Guides FY11 Sales
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts CELG Hot Sheet
Join SI Premium – FREE
Celgene Corp (NASDAQ: CELG) reported Q2 EPS of $0.89, $0.02 better than the analyst estimate of $0.87. Revenue for the quarter came in at $1.18 billion versus the consensus estimate of $1.12 billion.
Sees FY2011 revenue of $4.6-$4.7 billion, versus the consensus of $4.53 billion.
Sees FY2011 revenue of $4.6-$4.7 billion, versus the consensus of $4.53 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- Booz Allen Hamilton (BAH) Tops Q2 EPS by 28c, Misses on Revenue
- First Citizens Bancshares (FCNCA) reported Q3 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
